Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00583635 · ClinicalTrials.gov registry record
Early Pregnancy Antioxidant Supplementation in the Prevention of Preeclampsia
A clinical trial of Preeclampsia and Pregnancy Loss, sponsored by University of Mississippi Medical Center.
- Completed
- Registry status
- 684
- Enrollment target
- 1
- Study location
NCT00583635 is a study of Preeclampsia and Pregnancy Loss that has completed, run by University of Mississippi Medical Center. The registered enrollment target is 684 participants, below the 1,264-participant average among 39 other Preeclampsia trials with a reported enrollment target (46% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00583635, a study of Preeclampsia and Pregnancy Loss, has completed, sponsored by University of Mississippi Medical Center.
- COMPLETED
- Registry status
- 684 participants
- Enrollment target
- 1
- Study location
Study Summary
Use of Juice Plus+ food supplements, when initiated in the first trimester and used continuously thereafter, will result in a lower incidence of preeclampsia and pregnancy complications. This is a prospective randomized and blinded placebo controlled study sponsored by NSA, LLC of Memphis, TN.
Conditions Studied
Study Locations (1)
Mississippi
- University of Mississippi Medical Center - Jackson
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 684 participants |
| Start Date | 2004-05 |
| Est. Completion | 2011-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00583635
The ClinicalTrials.gov registry entry for NCT00583635 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 684 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,264-participant average among 39 other Preeclampsia trials with a reported enrollment target (46% lower). The listed sponsor is University of Mississippi Medical Center, which has 96 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Preeclampsia appearing as the primary indexed condition, and to 0 interventions.
NCT00583635 reports 1 study location spanning 1 distinct geographic area - top geographies include Mississippi.
Frequently Asked Questions
What is clinical trial NCT00583635 about?
NCT00583635 is a clinical study titled "Early Pregnancy Antioxidant Supplementation in the Prevention of Preeclampsia". Use of Juice Plus+ food supplements, when initiated in the first trimester and used continuously thereafter, will result in a lower incidence of preeclampsia and pregnancy complications. This is a prospective randomized and blinded placebo controlled study sponsored by NSA, LLC of Memphis, TN.
What is the current status of trial NCT00583635?
This trial is currently completed. The enrollment target is 684 participants. The study started on 2004-05. Estimated completion is 2011-08.
What conditions does trial NCT00583635 study?
This clinical trial studies the following conditions: Preeclampsia, Pregnancy Loss.
Who is sponsoring clinical trial NCT00583635?
This trial is sponsored by University of Mississippi Medical Center, which has 96 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00583635 being conducted?
This trial has 1 study location across Mississippi. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Preeclampsia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Spironolactone to Improve Pregnancy-Associated Hypertension Trajectories
RECRUITING · Phase 2
-
Eliminating Severe Maternal Morbidity With Heart Health Doulas Trial
RECRUITING · NA
-
Daily Aspirin Treatment After Preeclampsia
RECRUITING · Early Phase 1
-
Optimizing Cardiovascular Preventive Care for Women Following Hypertensive Disorders of Pregnancy
RECRUITING · NA
-
Exosome Cargo From Preeclampsia Patients
RECRUITING
-
Prenatal Aspirin and Postpartum Vascular Function
RECRUITING · Early Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.